Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

Service provision in the wake of a new funding model for community pharmacy

Authors: Alesha J. Smith, Shane L. Scahill, Jeff Harrison, Tilley Carroll, Natalie J. Medlicott

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

Recently, New Zealand has taken a system wide approach providing the biggest reform to New Zealand community pharmacy for 70 years with the aim of providing more clinically orientated patient centred services through a new funding model. The aim of this study was to understand the types of services offered in New Zealand community pharmacies since introduction of the new funding model, what the barriers are to providing these services.

Method

A survey of all community pharmacies were undertaken between August, 2014 and February, 2015. Basic descriptive statistics were completed and group comparisons were made using the chi squared test with significance set at p < 0.05.

Results

528 responses were received. Education and advice on prescription and non-prescription medicines were the two top listed services provided. There were no significant differences in service provision between rural and metro based pharmacies. Many pharmacies were considering introducing new patient centred services. Four of the top ten frequently provided services have no public funding attached. Costs and staff availability are the most common barriers to undertake services, more predominantly in patient centred services.

Conclusion

This study was the first to provide an evaluation of service provision in response to a new funding model for New Zealand Community Pharmacies. A broad range of services are being undertaken in New Zealand community pharmacies including patient-centred services. A number of barriers to service provision were identified. This study provides a baseline for the current levels of service provision upon which future studies can compare to and evaluate any changes in service provision with differing funding models going forward.
Literature
1.
go back to reference Blank RH, Burau V. Comparative health policy. New York: Palgrave Macmillan; 2013. Blank RH, Burau V. Comparative health policy. New York: Palgrave Macmillan; 2013.
2.
go back to reference Gauld R. The new health policy. London: McGraw-hill education (UK); 2009. Gauld R. The new health policy. London: McGraw-hill education (UK); 2009.
3.
go back to reference Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med. 2006;145:265–72.CrossRefPubMed Petersen LA, Woodard LD, Urech T, Daw C, Sookanan S. Does pay-for-performance improve the quality of health care? Ann Intern Med. 2006;145:265–72.CrossRefPubMed
4.
go back to reference Schoen C, Osborn R, Doty M, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries. Health Aff. 2007;26:717–34.CrossRef Schoen C, Osborn R, Doty M, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries. Health Aff. 2007;26:717–34.CrossRef
5.
go back to reference Duyvendak JW, Knijn T, Kremer M. Policy, people, and the new professional: de-professionalisation and re-professionalisation in care and welfare. Amsterdam: University Press; 2006.CrossRef Duyvendak JW, Knijn T, Kremer M. Policy, people, and the new professional: de-professionalisation and re-professionalisation in care and welfare. Amsterdam: University Press; 2006.CrossRef
7.
go back to reference Mak VS, Clark A, March G, Gilbert AL. The Australian pharmacist workforce: employment status, practice profile and job satisfaction. Aust Health Rev. 2013;37:127–30.CrossRefPubMed Mak VS, Clark A, March G, Gilbert AL. The Australian pharmacist workforce: employment status, practice profile and job satisfaction. Aust Health Rev. 2013;37:127–30.CrossRefPubMed
8.
go back to reference Petrakaki D, Barber N, Waring J. The possibilities of technology in shaping healthcare professionals:(re/De-) professionalisation of pharmacists in England. Soc Sci Med. 2012;75:429–37.CrossRefPubMed Petrakaki D, Barber N, Waring J. The possibilities of technology in shaping healthcare professionals:(re/De-) professionalisation of pharmacists in England. Soc Sci Med. 2012;75:429–37.CrossRefPubMed
9.
go back to reference Bissell P, Traulsen-Morgall J. Sociology and pharmacy practice. London: Pharmaceutical Press; 2005. Bissell P, Traulsen-Morgall J. Sociology and pharmacy practice. London: Pharmaceutical Press; 2005.
10.
go back to reference Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, Noyce P, Sketris I. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119:628–39.CrossRefPubMed Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K, Noyce P, Sketris I. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119:628–39.CrossRefPubMed
11.
go back to reference New Zealand Government. Pharmacy Action Plan: 2016 to 2020. Wellington: Ministry of Health; 2016. New Zealand Government. Pharmacy Action Plan: 2016 to 2020. Wellington: Ministry of Health; 2016.
12.
go back to reference Pharmaceutical Society of New Zealand. Focus on the Future: Ten Year Vision for Pharmacists: 2004–2014. Wellington: Pharmaceutical Society of New Zealand; 2004. Pharmaceutical Society of New Zealand. Focus on the Future: Ten Year Vision for Pharmacists: 2004–2014. Wellington: Pharmaceutical Society of New Zealand; 2004.
13.
go back to reference Armour CL, Smith L, Krass I. Community pharmacy, disease state management, and adherence to medication: a review. Dis Manag Health Out. 2008;16:245–54.CrossRef Armour CL, Smith L, Krass I. Community pharmacy, disease state management, and adherence to medication: a review. Dis Manag Health Out. 2008;16:245–54.CrossRef
14.
go back to reference Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.CrossRefPubMed Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.CrossRefPubMed
15.
go back to reference Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102–15.CrossRefPubMed Hatah E, Braund R, Tordoff J, Duffull SB. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. Br J Clin Pharmacol. 2014;77:102–15.CrossRefPubMed
16.
go back to reference District Health Board Shared Services. Community Pharmacy Services Agreement 2012: Propsal for CPSA Extension Feedback. Wellington: District Health Board Shared Services; 2015. District Health Board Shared Services. Community Pharmacy Services Agreement 2012: Propsal for CPSA Extension Feedback. Wellington: District Health Board Shared Services; 2015.
18.
go back to reference Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14:163–70.CrossRef Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. Int J Pharm Pract. 2006;14:163–70.CrossRef
19.
go back to reference Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42:861–8.CrossRefPubMed Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P. Practice change in community pharmacy: quantification of facilitators. Ann Pharmacother. 2008;42:861–8.CrossRefPubMed
20.
go back to reference Hattingh HL, Emmerton L, Ng Cheong Tin P, Green C: Utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect. 2015; Early View. Hattingh HL, Emmerton L, Ng Cheong Tin P, Green C: Utilization of community pharmacy space to enhance privacy: a qualitative study. Health Expect. 2015; Early View.
21.
go back to reference Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91.CrossRef Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract. 2007;15:185–91.CrossRef
24.
go back to reference Pharmacy Council of New Zealand. Pharmacy Council of New Zealand Workforce Demographics as at 30 June 2015. In. Wellington: Pharmacy Council of New Zealand; 2015. Pharmacy Council of New Zealand. Pharmacy Council of New Zealand Workforce Demographics as at 30 June 2015. In. Wellington: Pharmacy Council of New Zealand; 2015.
25.
go back to reference Oppenheim AN. Questionnaire design, interviewing and attitude measurement. London: Bloomsbury Academic; 2000. Oppenheim AN. Questionnaire design, interviewing and attitude measurement. London: Bloomsbury Academic; 2000.
26.
go back to reference Field A. Discovering statistics using SPSS: sage publications; 2009. Field A. Discovering statistics using SPSS: sage publications; 2009.
27.
go back to reference Kinsey H, Scahill S, Bye L, Harrison J. Funding for change: New Zealand pharmacists’ views on, and experiences of, the community pharmacy services agreement. Int J Pharm Pract. 2016;24(6):379–89. Kinsey H, Scahill S, Bye L, Harrison J. Funding for change: New Zealand pharmacists’ views on, and experiences of, the community pharmacy services agreement. Int J Pharm Pract. 2016;24(6):379–89.
28.
go back to reference Moore D, Love T, Boyle R, Poynton M. Community Pharmacy Services Agreement 2012 Evaluation: Short Form report. Wellington: Central Regions Technical Advisory Service; 2015. Moore D, Love T, Boyle R, Poynton M. Community Pharmacy Services Agreement 2012 Evaluation: Short Form report. Wellington: Central Regions Technical Advisory Service; 2015.
29.
go back to reference Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41:861–8.CrossRefPubMed Noyce PR. Providing patient care through community pharmacies in the UK: policy, practice, and research. Ann Pharmacother. 2007;41:861–8.CrossRefPubMed
30.
go back to reference Krska J, Saramunee K. Engaging the general Public's views to inform pharmaceutical policy. Res Social Adm Pharm. 2012;8:e4.CrossRef Krska J, Saramunee K. Engaging the general Public's views to inform pharmaceutical policy. Res Social Adm Pharm. 2012;8:e4.CrossRef
31.
go back to reference Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives. Res Social Adm Pharm. 2014;10:272–84.CrossRefPubMed Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P. How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives. Res Social Adm Pharm. 2014;10:272–84.CrossRefPubMed
32.
go back to reference Saramunee K, Krska J, Mackridge A, Suttajit S, Richards J, Phillips-Howard P. What factors do the general public consider in using a community pharmacy? Res Social Adm Pharm. 2012;8:e40.CrossRef Saramunee K, Krska J, Mackridge A, Suttajit S, Richards J, Phillips-Howard P. What factors do the general public consider in using a community pharmacy? Res Social Adm Pharm. 2012;8:e40.CrossRef
33.
go back to reference Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm. 2009;5:305–18.CrossRefPubMed Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom. Res Social Adm Pharm. 2009;5:305–18.CrossRefPubMed
34.
go back to reference Grootendorst P, Roochi M, Segal H. An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada. University of Tornoto: Leslie Dan Faculty of Pharmacy; 2008. Grootendorst P, Roochi M, Segal H. An economic analysis of the impact of reductions in generic drug rebates on community pharmacy in Canada. University of Tornoto: Leslie Dan Faculty of Pharmacy; 2008.
35.
go back to reference Scahill S, Harrison J, Carswell P, Shaw J. Health care policy and community pharmacy: implications for the New Zealand primary health care sector. N Z Med J. 2010;123(1317):41–51. Scahill S, Harrison J, Carswell P, Shaw J. Health care policy and community pharmacy: implications for the New Zealand primary health care sector. N Z Med J. 2010;123(1317):41–51.
36.
go back to reference Scahill S, Harrison J, Sheridan J. The ABC of New Zealand's ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract. 2009;17:135–42.CrossRefPubMed Scahill S, Harrison J, Sheridan J. The ABC of New Zealand's ten year vision for pharmacists: awareness, barriers and consultation. Int J Pharm Pract. 2009;17:135–42.CrossRefPubMed
37.
go back to reference Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health policy. 2010;95:1–9.CrossRefPubMed Bernsten C, Andersson K, Gariepy Y, Simoens S. A comparative analysis of remuneration models for pharmaceutical professional services. Health policy. 2010;95:1–9.CrossRefPubMed
38.
go back to reference Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: quantifying the needs of community pharmacies. Res Social Adm Pharm. 2010;6:163–73.CrossRefPubMed Feletto E, Wilson LK, Roberts AS, Benrimoj SI. Building capacity to implement cognitive pharmaceutical services: quantifying the needs of community pharmacies. Res Social Adm Pharm. 2010;6:163–73.CrossRefPubMed
39.
go back to reference Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.CrossRef Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.CrossRef
40.
go back to reference Rosenthal M, Grindrod KA, Lynd L, Marra CA, Bougher D, Wilgosh C, Tsuyuki RT. Pharmacists' perspectives on providing chronic disease Management Services in the Community—Part II: development and implementation of services. Can Pharm J. 2009;142:284–288. e281.CrossRef Rosenthal M, Grindrod KA, Lynd L, Marra CA, Bougher D, Wilgosh C, Tsuyuki RT. Pharmacists' perspectives on providing chronic disease Management Services in the Community—Part II: development and implementation of services. Can Pharm J. 2009;142:284–288. e281.CrossRef
41.
go back to reference Boechler L, Despins R, Holmes J, Northey J, Sinclair C, Walliser M, Perepelkin J. Advocacy in pharmacy: changing “what is” into “what should be”. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2015;148:138–41.CrossRefPubMed Boechler L, Despins R, Holmes J, Northey J, Sinclair C, Walliser M, Perepelkin J. Advocacy in pharmacy: changing “what is” into “what should be”. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2015;148:138–41.CrossRefPubMed
42.
go back to reference Scahill SL. Placing “culture” at the center of social pharmacy practice and research. Res Social Adm Pharm. 2013;9:1–3.CrossRefPubMed Scahill SL. Placing “culture” at the center of social pharmacy practice and research. Res Social Adm Pharm. 2013;9:1–3.CrossRefPubMed
Metadata
Title
Service provision in the wake of a new funding model for community pharmacy
Authors
Alesha J. Smith
Shane L. Scahill
Jeff Harrison
Tilley Carroll
Natalie J. Medlicott
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3120-z

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue